Biotech Profit Taking Picks Up: MO Stocks Take A Hit-Caution
The Rayno Life Science Portfolio was down 1.76% today which in itself is not alarming but given the weekly volatility against a back-drop of macro issues it is time to avoid complacency. Let's start with the MO players who are those investors with more money than reason but nonetheless have...
Debt Negotiations Stall Market;Gold Up $15 at $1615
Note: we will return from vacation this week and focus on companies attending the AACC (American Association of Clinical Chemistry)Meeting in Atlanta this week). Market Down 0.5% as Both Parties Struggle to Come up with Debt Ceiling Plan One half hour into trading the market has cut losses in...
Surprise Rally Takes Everything Up:Technology OutPerforms Biotechnology
Life Science Stocks Follow NASDAQ Up: EXAS, MITI, REGN Soar Large healthcare companies report over next two weeks Stocks roared today on IBM earnings last night, debt ceiling negotiation progress with bipartisan Senators,and surge in housing starts. AAPL piled on after hours with a huge beat on...
Bulls Better Off with QQQ than Pure Biotech for Now
With the QQQ you are still Bullish on Biotech We mentioned yesterday that those wanting to be bullish large cap NASDAQ stocks but remain bullish on biotech would be better off with a QQQ position as pure play biotechs are due for a rest. Today the QQQ is up 1.69% compared to biotech ETF's...
Life Science Stocks In Third Day of Sell-Off
Todays' Movers : CSII and IMGN Life Science and Drug stocks hit their third day of selling about 4% off July highs but 6% higher than June lows. The bellwether ETF IBB remains 6% above intermediate support of 100.The healthcare sector overall was down 0.88% about the same as the S&P. The...